Seroprevalence of hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria

Virology Journal

Volumn 9, Issue , 2012, Pages

  Kolawole, Olatunji M ^a   Wahab, Abideen A ^b   Adekanle, Daniel A ^c   Sibanda, Timothy ^a   Okoh, Anthony I ^a  

^a UNIVERSITY OF FORT HARE   (South Africa)

^b OSUN STATE UNIVERSITY   (Nigeria)

^c LAUTECH TEACHING HOSPITAL   (Nigeria)

Author keywords

Enzyme linked immunosorbent assay; Hematological parameters; Hepatitis B surface antigen; Risk factors

Indexed keywords

HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; EDUCATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE COUNT; FAMILY; FEMALE; GESTATIONAL AGE; GRAVITY; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MATERNAL AGE; NEUTROPHIL COUNT; NIGERIA; OCCUPATION; PREGNANT WOMAN; PRENATAL CARE; PREVALENCE; RISK FACTOR; SEROEPIDEMIOLOGY; SEROPREVALENCE; TEACHING HOSPITAL; THROMBOCYTE COUNT; VENOUS BLOOD; VIRUS CARRIER;

ADOLESCENT; ADULT; AGE FACTORS; ERYTHROCYTE INDICES; FEMALE; GESTATIONAL AGE; GRAVIDITY; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; NIGERIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 84871571692     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-317     Document Type: Article

References (40)

1. Sexually transmitted diseases treatment guidelines. CDC, MMWR Recomm Rep 2002 51 RR-6 1 78 15580804
2. WHO, Advanced immunization management. Hepatitis. Fact sheet No 2005
3. Patient to patient transmission of hepatitis B virus associated with oral Surgery. Redd HT, Baunbach H, Kohn W, J infect Dis 2007 195 9 1311 4 10.1086/513435 17397000 (Pubitemid 46649616)
4. CDC, Hepatitis transmitted by a human bite Morb. Mort. Wkly Rep 1974 23 24
5. Protection against viral hepatitis: recommendation of the immunization practices advisory committee. ACIP, Morb Mort Wkly Rep 1990 39 RR-2
6. HBs antigen carrier state in pregnant women in Bobo Dioulasso (Burkinafaso). Nacos B, Dao B, Dahourou M, et al. Dakar Med 2000 42 2 188 190
7. Epidemiological patterns of hepatitis B virus (HBV) infection in highly endemic areas. Edmund WJ, Medley GF, Nokes DJ, O'Callaghan CJ, Whittle HC, Hall AJ, Epidemiol Infect 1996 313 325 (Pubitemid 26345241)
8. Hepatitis B virus infection in children and adults in northern Nigeria: a preliminary survey. Fakunle YM, Abdulraham MB, Whittel HC, Trans R Soc Trop Med Hyg 1981 75 5 625 629
9. The seroprevalence of hepatitis B surface antigen and human immunodeficiency virus among pregnant women in Anambra State, Nigeria. Christy NE, Dennis EA, Gilbert ON, et al. Shtraz E-medical J 2004 5 2 1 25
10. Vaccination against hepatitis A and B: development deployment and elusion. Zuckerman JN, Curr Opin Infect Dis 2006 19 5 456 9 10.1097/01.qco. 0000244051.23511.09 16940869 (Pubitemid 44338105)
11. Implication of Post vaccination hepatitis B surface antigenemia in the management of exposure to body fluids. Martin-Ancel A, Casas ML, Bonet B, Infect control Hosp Epidemiol 2004 25 7 611 3 10.1086/502449 15301037 (Pubitemid 38954495)
12. MCS, Mayo Clinic Staff. Hepatitis B prevention. Mayo Clinic http:www.mayoclinic.com/health/hepatitis B/DS
13. Haematological values in pregnancy in Jos. Onwukeme KE, Uguru VE, West Afr J Med 1990 9 70 75 2268572
14. Observation on some hematological parameters of Nigerian women during pregnancy. Osoagbaka OU, Haruna RH, Anokwuru OC, J Med Invest Pract 2000 1 45 48
15. Pregnancy and the erythrocyte sedimentation rate. Kei N, J Immune Based Therapies Vaccines 2004 2 4 45 57
16. Leucocyte phagocytosis and circulation immune complexes in mothers after child birth. Arinola OG, Obisesan K, Salimonu LS, Onifade R, Afolabi K, West Afr J Med 2004 23 256 9 15587842 (Pubitemid 39530286)
17. Detrimental effects of hepatitis B virus infection on the development of product of conception. Pavel A, Tirsia E, Maior E, Cristea A, Virologie 1983 34 34 40
18. The Impact of maternal HBsAg carrier status on pregnancy outcomes: A case-control study. Tse KY, Lo LF, Lao T, J Hepatol 2005 43 371 75
19. Seroprevalence of hepatitis B surface antigen among patients attending Aminu Kano Teaching Hospital. Nwokedi E, Odimayo MS, Emokpae AM, Yahaya IA, Sadiq MN, Okwori EE, Kano Niger J Med 2010 19 4 423 6
20. Viral hepatitides in voluntary blood donors in Yola, Nigeria. Olokoba AB, Salawu FK, Danburam A, Desalu OO, Olokoba LB, Wahab KW, Badung LH, Tidi SK, Midala J, Aderibigbe S, Abdulrahman MB, Babalola OM, Abdukkarim A, Euro J Sci Res 2009 31 3 329 334
21. Maternal and neonatal seroprevalence of hepatitis B surface antigen (HBsAg) in Benin city, Nigeria. Onakewhor JUE, Offor E, Okonofua FE, J Obs Gynaecol 2001 21 6 583 586 10.1080/01443610120085528 (Pubitemid 34014286)
22. Seroprevalence and biochemical features of hepatitis B surface antigenemia in patients with HIV-1 infection in Lagos. Iwalokun BA, Hodonu SO, Olaleye BM, Olabisi OA, Afri J Med Med Sci 2006 35 3 337 43
23. Seroprevalence of hepatitis B surface antigenemia among health care workers in a Nigerian tertiary health institution. Ajayi AO, Komolafe AO, Ajumobi K, Niger J Clin Pract 2007 10 4 287 9 18293636
24. Seroprevalence of hepatitis B Surface antigen among pregnant women. Dawaki SS, Kawo AH, Nig J Microbiol 2006 20 1 705 709
25. Araoye MO, Sample size determination. Research methodology with statistics for health and social sciences 2003 118 121
26. Neoplasms of the liver. Isselbacher KJ, Wands JR, et al. Harrison's Principle of Internal Medicine (12th Edition) New York, USA: McGraw-Hill, Wilson JD, Braunwald E, Isselbacher K, 1991 1350 1352 23275668
27. Seroprevalence of hepatitis B and C and human immunodeficiency type 1 virus in a rural population from the Republic of Equatorial Guinea. Miren B, Asun S, Mario S, Enrigue G, Iboy DO, Ramon C, Trans R Soc Trop Med Hyg 1999 93 250 252 10.1016/S0035-9203(99)90010-X 10492751 (Pubitemid 29348813)
28. Hepatitis B virus seroprevalence among pregnant women. Awosere KE, Arinola OG, Uche LN, J Med Lab Sc 1999 3 2 23 27
29. The declining HBsAg carriage rate in pregnant women in Hong Kong. Kong KL, Cho Y, Lee SS, Epidemiol Infect 1997 199 281 283 (Pubitemid 27474811)
30. Risk factors and Seroprevalence of hepatits B surface antigenemia in mothers and their pre-school age children in Ilorin, Nigeria. Agbede OO, Iseniyi JO, Kolawole OM, Ojuawo A, Future Med Therapy 2007 4 1 67 72 (Pubitemid 46322252)
31. Prevalence of hepatitis B surface antigen among women of childbearing age. Aganga WOM, Akanmu AS, Akinsete A, Njoku OS, Afr J Rep 1999 3 1 45 50 10.2307/3583228
32. HBV, HCV co-infection among blood donors in Nigeria. Opaleye OO, Zakariyahu TO, Tijani BA, Bakarey AS, Indian J Pathol Microbiol 2010 53 182 3 10.4103/0377-4929.59229 20090268
33. Soxhami RL, Moxhan J, Textbook of Medicine (1st Ed) Churchill Livingstone city, United Kingdom: Longman Group Publishers 1991 634 635
34. Prevalence and significance of sexually transmitted diseases among women. Duncan ME, Tibaus G, Pelger A, Ethiop J Health Dev 1995 9 31 40
35. Epidemiology of Chronic Hepatitis C infection in sub-Saharan Africa. Maddawa V, Burgress C, Drucker E, Lancet Infect 2002 2 293 302 10.1016/S1473-3099(02)00264-5 (Pubitemid 34464740)
36. Further studies on a new human isoprecipitin system (Australia antigen). Alter HJ, Blumberg BS, Blood 1966 27 3 297 309 5930797
37. The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease. Shale MJ, Br Med Bull 2009 92 1 61 77 10.1093/bmb/ldp036 19855102
38. Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in Nigeria. Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankale J, Ekong E, Murphy R, Kanki P, Thio CL, Clin Infect Dis 2009 49 8 1268 1273 10.1086/605675 19772386
39. Apoptosis observed in peripheral T lymphocytes from patients with chronic hepatitis B. Nakamura K, Yuh K, Sugyo S, Shijo H, Kimura N, Okumura M, Gastroenterology 1996 111 156 164 10.1053/gast.1996.v111.pm8698194 8698194 (Pubitemid 26226895)
40. Possible mechanisms underlying peripheral lymphocyte activation in chronic liver disease and asymptomatic HBsAg carriers. Raptopoulou-Gigi M, Orphanou-Koumerkeridou H, Lagra F, Allergol Immunopathol (Madr) 1989 17 145 148